Alto Ingredients, Inc. Reports First Quarter 2022 Results

Rhea-AI Summary

Alto Ingredients, Inc. (NASDAQ: ALTO) reported a 41% increase in net sales to $308 million for Q1 2022 compared to Q1 2021, aided by strategic investments in specialty alcohols and essential ingredients. Despite this growth, the company faced operational challenges, resulting in a net loss of $2.9 million, or $0.04 per share. Key metrics included a gross profit drop to $4.8 million and an Adjusted EBITDA of $4.4 million. The acquisition of Eagle Alcohol aims to enhance market position, while cash reserves decreased to $36.2 million.

Positive

• Net sales increased by 41% to $308.1 million compared to Q1 2021.
• Strategic acquisition of Eagle Alcohol for expanding product distribution in premium spirits.
• Launch of quality and ESG initiatives to enhance market position.

Negative

• Net loss of $2.9 million compared to a net income of $4.4 million in Q1 2021.
• Gross profit decreased to $4.8 million from $13.8 million year-over-year.
• Operating loss of $2.9 million, down from an operating income of $5.6 million.

• Increased Net Sales 41% to $308 Million vs. Q1 2021
  
• Integrated Acquisition of Specialty Alcohol Distributor, Eagle Alcohol
• Launched Quality and ESG Initiatives
  

SACRAMENTO, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols and essential ingredients, reported its financial results for the quarter ended March 31, 2022.

“Our first quarter results validated our strategy to invest in specialty alcohols and essential ingredients,” said Mike Kandris CEO of Alto Ingredients. “Product diversification, with increased sales from higher margin products combined with operational improvements, partially offset the impact of the challenging commodities market. To further our strategy, we acquired a small-package distributor serving premium spirits markets in January and qualified for additional certifications valuable to pharmaceutical customers in February. These initiatives broadened our opportunities and enhanced our position in the marketplace. We are evaluating new capital expenditure programs to create additional long-term stakeholder value. We remain focused on executing on our strategic goals, investing for future growth and diversifying our product portfolio.”

Financial Results for the Three Months Ended March 31, 2022 Compared to 2021

•  Net sales were $308.1 million, compared to $218.7 million.
•  Cost of goods sold was $303.3 million, compared to $204.9 million.
•  Gross profit was $4.8 million, compared to $13.8 million.
•  Selling, general and administrative expenses were $7.6 million, compared to $7.0 million.
•  Operating loss was $2.9 million, compared to operating income of $5.6 million.
•  Net loss available to common stockholders was $2.9 million, or $0.04 per share, compared to net income of $4.4 million, or $0.06 per diluted share.
•  Adjusted EBITDA was $4.4 million, compared to $13.4 million.
•  Cash and cash equivalents were $36.2 million at March 31, 2022, compared to $50.6 million at December 31, 2021.

First Quarter 2022 Results Conference Call
Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Monday, May 9, 2022, and will deliver prepared remarks via webcast followed by a question-and-answer session.

The webcast for the call can be accessed from Alto Ingredients website at www.altoingredients.com. Alternatively, you may dial the following number up to ten minutes prior to the scheduled conference call time: (866) 777-2509. International callers should dial (412) 317-5413. Please ask to join the Alto Ingredients call. The webcast will be archived for replay on Alto Ingredients’ website for one year. In addition, a telephonic replay will be available at 8:00 p.m. Eastern Time on Monday, May 9, 2022, through 8:00 p.m. Eastern Time on Wednesday, May 16, 2022. To access the replay, please dial (877) 344-7529. International callers should dial (412) 317-0088. The pass code will be 7162739.

Use of Non-GAAP Measures
Management believes that certain financial measures not in accordance with generally accepted accounting principles ("GAAP") are useful measures of operations. The company defines Adjusted EBITDA as unaudited net income (loss) attributed to Alto Ingredients, Inc. before interest expense, interest income, provision (benefit) for income taxes, asset impairments, loss on extinguishment of debt, acquisition-related expense, fair value adjustments, and depreciation and amortization expense. A table is provided at the end of this release that provides a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, net income (loss) attributed to Alto Ingredients, Inc. Management provides this non-GAAP measure so that investors will have the same financial information that management uses, which may assist investors in properly assessing the company's performance on a period-over-period basis. Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) attributed to Alto Ingredients, Inc. or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA has limitations as an analytical tool and you should not consider this measure in isolation or as a substitute for analysis of the company's results as reported under GAAP.

About Alto Ingredients, Inc.
Alto Ingredients, Inc. (ALTO) is a leading producer and distributor of specialty alcohols and essential ingredients. The company is focused on products for four key markets: Health, Home & Beauty; Food & Beverage; Essential Ingredients; and Renewable Fuels. The company’s customers include major food and beverage companies and consumer products companies. For more information, please visit www.altoingredients.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Statements and information contained in this communication that refer to or include Alto Ingredients’ estimated or anticipated future results or other non-historical expressions of fact are forward-looking statements that reflect Alto Ingredients’ current perspective of existing trends and information as of the date of the communication. Forward looking statements generally will be accompanied by words such as “anticipate,” “believe,” “plan,” “could,” “should,” “estimate,” “expect,” “forecast,” “outlook,” “guidance,” “intend,” “may,” “might,” “will,” “possible,” “potential,” “predict,” “project,” or other similar words, phrases or expressions. Such forward-looking statements include, but are not limited to, statements concerning the benefits of the acquisition of Eagle Alcohol and plant and product certifications; and Alto Ingredients’ other plans, objectives, expectations and intentions. It is important to note that Alto Ingredients’ plans, objectives, expectations and intentions are not predictions of actual performance. Actual results may differ materially from Alto Ingredients’ current expectations depending upon a number of factors affecting Alto Ingredients’ business. These factors include, among others, adverse economic and market conditions, including for specialty alcohols and essential ingredients; export conditions and international demand for the company’s products; fluctuations in the price of and demand for oil and gasoline; raw material costs, including production input costs, such as corn and natural gas; and the effects – both positive and negative – of the coronavirus pandemic and its resurgence or abatement. These factors also include, among others, the inherent uncertainty associated with financial and other projections; the anticipated size of the markets and continued demand for Alto Ingredients’ products; the impact of competitive products and pricing; the risks and uncertainties normally incident to the specialty alcohol production and marketing industries; changes in generally accepted accounting principles; successful compliance with governmental regulations applicable to Alto Ingredients’ facilities, products and/or businesses; changes in laws, regulations and governmental policies; the loss of key senior management or staff; and other events, factors and risks previously and from time to time disclosed in Alto Ingredients’ filings with the Securities and Exchange Commission including, specifically, those factors set forth in the “Risk Factors” section contained in Alto Ingredients’ Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 15, 2022.

Media Contact:                 
Bryon McGregor, Alto Ingredients, Inc., 916-403-2768, mediarelations@altoingredients.com
Company IR Contact:                 
Michael Kramer, Alto Ingredients, Inc., 916-403-2755, investorrelations@altoingredients.com
IR Agency Contact:
Kirsten Chapman, LHA Investor Relations, 415-433-3777, investorrelations@altoingredients.com

ALTO INGREDIENTS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited, in thousands, except per share data)

	Three Months Ended March 31,
		2022				2021
Net sales	$	308,118			$	218,734
Cost of goods sold		303,345				204,897
Gross profit		4,773				13,837
Selling, general and administrative expenses		7,629				7,014
Asset impairment		—				1,200
Income (loss) from operations		(2,856	)			5,623
Interest expense, net		(200	)			(1,885	)
Other income, net		454				940
Income (loss) before provision for income taxes		(2,602	)			4,678
Provision for income taxes		—				—
Net income (loss)	$	(2,602	)		$	4,678
Preferred stock dividends	$	(312	)		$	(312	)
Net income (loss) available to common stockholders	$	(2,914	)		$	4,366
Net income (loss) per share, basic and diluted	$	(0.04	)		$	0.06
Weighted-average shares outstanding, basic		71,390				70,351
Weighted-average shares outstanding, diluted		71,390				72,464

ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS
(unaudited, in thousands, except par value)

ASSETS		March 31, 2022							December 31, 2021
Current Assets:
Cash and cash equivalents		$	36,184					$	50,612
Restricted cash			23,799						11,513
Accounts receivable, net			80,611						86,888
Inventories			58,491						54,373
Derivative instruments			19,498						15,839
Notes receivable, current			12,385						3,125
Other current assets			10,245						7,176
Total current assets			241,213						229,526
Property and equipment, net			220,996						222,550
Other Assets:
Right of use operating lease assets, net			15,099						13,413
Notes receivable, noncurrent			—						11,641
Intangible assets, net			9,460						2,678
Goodwill			5,958						—
Other assets			5,142						5,145
Total other assets			35,659						32,877
Total Assets		$	497,868					$	484,953

ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS (CONTINUED)
(unaudited, in thousands, except par value)

LIABILITIES AND STOCKHOLDERS’ EQUITY
						March 31, 2022								December 31, 2021
Current Liabilities:
Accounts payable – trade					$	21,750							$	23,251
Accrued liabilities						19,479								21,307
Current portion – operating leases						4,297								3,909
Derivative instruments						27,487								13,582
Other current liabilities						7,168								7,553
Total current liabilities						80,181								69,602
Long-term debt						53,681								50,361
Operating leases, net of current portion						10,705								9,382
Other liabilities						10,336								10,394
Total Liabilities						154,903								139,739
Stockholders’ Equity:
Alto Ingredients, Inc. Stockholders’ Equity:
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: no shares issued and outstanding as of
March 31, 2022 and December 31, 2021
Series B: 927 shares issued and outstanding as of
March 31, 2022 and December 31, 2021						1								1
Common stock, $0.001 par value; 300,000 shares authorized;
74,411 and 72,778 shares issued and outstanding as of
March 31, 2022 and December 31, 2021, respectively						74								73
Non-voting common stock, $0.001 par value; 3,553 shares
authorized; 1 share issued and outstanding as of March 31,
2022 and December 31, 2021						—								—
Additional paid-in capital						1,037,869								1,037,205
Accumulated other comprehensive loss						(284					)			(284				)
Accumulated deficit						(694,695					)			(691,781				)
Total Stockholders’ Equity						342,965								345,214
Total Liabilities and Stockholders’ Equity					$	497,868							$	484,953

Reconciliation of Adjusted EBITDA to Net Income (Loss)

	Three Months Ended March 31,
(in thousands) (unaudited)		2022				2021
Net income (loss)	$	(2,602	)		$	4,678
Adjustments:
Interest expense		200				1,885
Interest income		(158	)			(184	)
Acquisition-related expense		875				—
Asset impairments		—				1,200
Depreciation and amortization expense		6,134				5,860
Total adjustments		7,051				8,761
Adjusted EBITDA	$	4,449			$	13,439

Commodity Price Performance

	Three Months Ended March 31,
(unaudited)		2022				2021
Renewable fuel production gallons sold (in millions)		49.2				39.0
Specialty alcohol production gallons sold (in millions)		23.3				19.0
Third party renewable fuel gallons sold (in millions)		30.7				54.0
Total gallons sold (in millions)		103.2				112.0
Total gallons produced (in millions)		74.3				58.0
Production capacity utilization		86	%			52	%
Average sales price per gallon	$	2.46			$	1.94
Average CBOT ethanol price per gallon	$	2.16			$	1.60
Corn cost per bushel – CBOT equivalent	$	6.22			$	4.98
Average basis	$	0.64			$	0.29
Delivered corn cost	$	6.86			$	5.27
Total essential ingredients tons sold (in thousands)		398.8				276.9
Essential ingredient return % (1)		36.4	%			40.0	%

________________
(1) Essential ingredients revenue as a percentage of delivered cost of corn.

Segment Financials

(in thousands) (unaudited)				Three Months Ended March 31,
				2022								2021
Net sales
Pekin Campus production, recorded as gross:
Alcohol sales			$	116,050							$	95,083
Essential ingredient sales				55,280								45,077
Intersegment sales				256								1,473
Total Pekin Campus sales				171,586								141,633
Marketing and distribution:
Alcohol sales, gross			$	53,926							$	57,010
Alcohol sales, net				351								452
Intersegment sales				2,996								2,244
Total marketing and distribution sales				57,273								59,706
Other production, recorded as gross:
Alcohol sales			$	59,805							$	15,969
Essential ingredient sales				18,938								5,143
Intersegment sales				12								305
Total Other production sales				78,755								21,417
Corporate and other				3,768								—
Intersegment eliminations				(3,264					)			(4,022			)
Net sales as reported			$	308,118							$	218,734
Cost of goods sold:
Pekin Campus production			$	168,881							$	128,864
Marketing and distribution				54,716								53,958
Other production				78,244								24,117
Corporate and other				2,872								—
Intersegment eliminations				(1,368					)			(2,042			)
Cost of goods sold as reported			$	303,345							$	204,897
Gross profit (loss):
Pekin Campus production			$	2,705							$	12,769
Marketing and distribution				2,557								5,748
Other production				511								(2,700			)
Corporate and other				896								—
Intersegment eliminations				(1,896					)			(1,980			)
Gross profit (loss) as reported			$	4,773							$	13,837

FAQ

What were Alto Ingredients' net sales in Q1 2022?

Alto Ingredients reported net sales of $308.1 million in Q1 2022, a 41% increase compared to Q1 2021.

What was Alto Ingredients' net loss per share for Q1 2022?

The net loss available to common stockholders was $2.9 million, or $0.04 per share in Q1 2022.

How did Alto Ingredients' gross profit change in Q1 2022?

Gross profit decreased to $4.8 million in Q1 2022, down from $13.8 million in Q1 2021.

What is the significance of the Eagle Alcohol acquisition for ALTO?

The acquisition of Eagle Alcohol enhances Alto Ingredients' distribution capabilities in the premium spirits market.

What were Alto Ingredients' cash reserves at the end of Q1 2022?

Alto Ingredients had cash and cash equivalents of $36.2 million at March 31, 2022.